SWEDISH ORPHAN BIOVI

SOBI
Delayed Quote. Delayed  - 10/20 11:29:56 am
233.6SEK --.--%

Turn to zoom
Prev.233.6000
Open233.4000
High233.9000
Low232.5000
Volume445 824
Latest news
53m ago
5d ago
5d ago
5d ago
Chart SWEDISH ORPHAN BIOVITRUM AB (PUBL)
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBullishBullish
Resistance238245243
Spread/Res.-1,8%-4,5%-3,9%
Spread/Supp.0,17%34%28%
Support233175183
Financials
Sales 2021 14 941 M 1 742 M 1 742 M
Net income 2021 2 099 M 245 M 245 M
Net Debt 2021 9 618 M 1 122 M 1 122 M
P/E ratio 2021 33,0x
Yield 2021 -
Capitalization 68 946 M 8 020 M 8 041 M
EV / Sales 2021 5,26x
EV / Sales 2022 4,72x
Nbr of Employees 1 537
Free-Float 59,5%
Company
Swedish Orphan Biovitrum publ AB is a Sweden-based pharmaceutical company. The Company develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the...

>> Read more
Sector :
Biopharmaceuticals
Calendar :
2021-10-28 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 233,60 SEK
Average target price 219,63 SEK
Spread / Average Target -5,98%